SAScion Asset Management, LLC

Institutional investor · Portfolio as of Q2 2025No 13F holdings reported for quarters after Q3 2025.

Top Holdings15 positions

Checking export access…
Activity:
UNHUNH
CALL

UNITEDHEALTH GROUP INC

350,000$109.2M18.9%———
New
—
REGNREGN
CALL

REGENERON PHARMACEUTICALS

200,000$105M18.2%———
New
—
LULULULU
CALL

LULULEMON ATHLETICA INC

400,000$95M16.4%———
New
—
METAMETA
CALL

META PLATFORMS INC

100,000$73.8M12.8%———
New
—
ELEL
CALL

LAUDER ESTEE COS INC

500,000$40.4M7.0%———
New
—
JDJD
CALL

JD.COM INC

1M$32.6M5.6%———
New
—
BABABABA
CALL

ALIBABA GROUP HLDG LTD

250,000$28.4M4.9%———
New
—
ASMLASML
CALL

ASML HOLDING N V

25,000$20M3.5%———
New
—
VFCVFC
CALL

V F CORP

1.5M$17.6M3.0%———
New
—

LAUDER ESTEE COS INC

150,000$12.1M2.1%$68.75+42.62%
3 qtrssince 2024-Q4
Decreased
0

LULULEMON ATHLETICA INC

50,000$11.9M2.1%$235.020.00%
1 qtr
New
75

BRUKER CORP

250,000$10.3M1.8%$41.690.00%
1 qtr
New
66

REGENERON PHARMACEUTICALS

15,000$7.9M1.4%$519.56+43.69%
1 qtr
New
66

MERCADOLIBRE INC

3,000$7.8M1.4%$2,560.05-26.18%
1 qtr
New
66

UNITEDHEALTH GROUP INC

20,000$6.2M1.1%$305.12+24.31%
1 qtr
New
65
$578.3M
Reported value
15
Positions
Q2 2025
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+115%Q4'23$94.6M+9%Q1'24$103.5M-49%Q2'24$52.5M+58%Q3'24$83.1M-7%Q4'24$77.4M-27%Q2'25$56.3M
Activity profile
$ moved · Q2'25
New75%Increased0%Decreased0%Exited25%
Composition
Equity vs derivatives
Equity10%Puts0%Calls90%
Holding period
Avg 1.9 quarters
<1Q80%1-4Q7%1-2Y7%2Y+7%

Scion Asset Management, LLC reported holdings worth $578.3M across 15 positions as of Q2 2025. Top holdings: UNH calls (18.9%), REGN calls (18.2%), LULU calls (16.4%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.

Q2 2025 Summary

Added 5 new positions, trimmed 1. Top move: LULU (NEW, conviction 75). Portfolio: $578M across 15 positions.

Top holdings by portfolio weight

Total AUM$56M
EL2.10%
LULU2.05%
BRKR1.78%
REGN1.36%
MELI1.36%
UNH1.08%

Portfolio allocation by GICS sector

Sectors3
Healthcare43.40%
Consumer Cyclical35.05%
Consumer Defensive21.55%

Behavioral investing profile

7-dimension, SEC 13F-derived research score

No 13F holdings reported for quarters after Q3 2025.

Weak(1.0 / 5.0)
Holdings P&LNo data
Conviction50
Concentration0
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used